China: Time To Review Pricing Practices In Your China Operations: Part II – Recent NDRC Investigations

Last Updated: 27 August 2013
Article by Hannah C. L. Ha, John M. Hickin and Wendy Y.S. Thian

Keywords: pricing practices, China, NDRC investigations, AML

Part II – Recent NDRC Investigations

In the second of a special three-part legal update advising clients on the significant increase in Anti- Monopoly Law (AML) enforcement activity, we focus on the National Development and Reform Commission (NDRC), the regulator responsible for enforcing the law's conduct rules to the extent they directly relate to pricing matters (e.g., price-fixing cartels or unfair high pricing by dominant firms etc.).

In part 1 of this update, we highlighted recent enforcement activity by the State Administration of Industry and Commerce (SAIC). In this update, we look at the NDRC's high profile investigations into the pricing of infant formula, jewellery and drugs, in what appears to be an enforcement agenda targeted at foreign companies operating in China. In light of the recent series of investigations and new record fines for resale price maintenance (RPM) practices, clients should be mindful of the focus on multinationals and be on the alert for any pricing practices that could raise issues under the AML.

Record fines imposed on baby milk powder producers for RPM practices

Chinese news reports began to emerge in early July of a price fixing investigation of infant formula producers, most of which were foreign firms in China. On 6 August, after only five months of investigation, the NDRC imposed record fines totalling RMB669 million on six producers (ranging from 3 to 6 per cent of 2012 sales revenue) for setting minimum resale prices with distributors in breach of Article 14 of the AML, despite some of them having agreed to lower their prices in light of the investigation.

According to the NDRC's statement, all of the six producers have admitted to RPM practices, and were unable to prove to the satisfaction of the NDRC that their actions fell within the exemptions under Article 15 of the AML. The companies had imposed sanctions on the distributors that did not comply, including direct and disguised fines, deductions in rebates and refusals to supply. Biostime was singled out by the regulator for its "failure to proactively cooperate with the investigation", and accordingly received a fine amounting to 6 per cent of its sales revenue in 2012 (RMB162,900,000). A pricing official at the NDRC has been quoted in the press warning of increasingly severe penalties in cases where businesses knowingly breach the law.

In addition to the payment of fines, the six companies will also be implementing corrective measures, including immediately modifying distribution agreements, sales and business policies to comply with the law, providing competition law compliance training to staff, and taking "practical action to eliminate the consequences" of past violations.

The NDRC's decision comes shortly after the Shanghai High People's Court's judgment in the Beijing Rainbow/Johnson & Johnson case on 1 August , which explicitly stated that RPM per se does not constitute an infringement of the AML. The regulator however did not clarify whether it applied the per se illegal or rule of reason approach, although according to its press release, the companies' actions led to inflated prices for baby milk powder, severely excluding and restricting price competition, and resulting in detriment to consumers.

Three other companies avoided penalties as they voluntarily cooperated with the NDRC under its leniency programme by providing important evidence and have voluntarily undertaken to address the regulator's concerns.

The infant formula investigation is one which has drawn significant media attention around the world, with a number of reports questioning whether the protection of competition is the regulator's real concern. The Chinese government has been under increasing pressure to keep prices of baby milk powder under control; prices have risen by 30 per cent since the melamine scandal in 2008, which drove up the demand for imported powder. Five years on, Chinese consumers have yet to regain trust in the government's ability to deal effectively with food quality control issues or confidence in local brands.

Hong Kong retailers avoid fines in Shanghai jewellery cartel case

According to the NDRC's announcement of 13 August, five Shanghai-based retailers and the Shanghai Gold & Jewelry Trade Association have been fined a total of RMB10.59 million for fixing the price of gold and platinum products in breach of Articles 13 and 16 of the AML respectively. The retailers' fines, which were significantly lower than those imposed in the infant formula case, represented 1 per cent of their 2012 revenues, while the association received the highest possible fine for a trade association (RMB500,000). Members of the trade association, including those fined by the regulator, had implemented a pricing guideline which agreed on the calculation method, formulas and permitted variations in the pricing of gold and platinum jewellery.

The fined entities have agreed to a number of corrective measures, including abolishing the pricing guidelines and promising not to facilitate or participate in any further pricing-related discussions with each other.

News of the jewellery investigation, which initially targeted 13 retailers, was first reported around the same time as the baby milk powder investigation. Hong Kong-based jewellers were reported by the Chinese media to be amongst those probed by the NDRC, although they have denied any anti-competitive practices in the pricing of their jewellery and have not been named in the NDRC's statement.

Inquiries into drug pricing and costs

The NDRC's Evaluation Centre of Drug Pricing is currently investigating the production costs and pricing of 60 drug makers, amongst them foreign firms. The investigations are not, strictly speaking, AML related, but have been launched in light of the Price Law, Drug Administrative Law and "other relevant regulations".

According to the NDRC's announcement of 2 July, the regulator is initiating a three-month investigation of prices charged by certain foreign and domestic drug makers. The NDRC's previous monitoring of drug pricing seems to have relied on self reporting by companies, while the current investigation will involve a review and verification of financial records and documents by officials, as well as on-site inspections.

A second investigation into the costs of certain international and Chinese drug companies will look into production and distribution costs as well as pricing for 2010-12.

Potential new investigations aimed at foreign car makers and other industries

Recent press reporting from China suggests the China Automobile Dealers Association (CADA) has been collecting data on the price of all foreign cars sold in the country for the NDRC since last year. While a CADA official has been quoted saying that the NDRC was investigating whether carmakers were setting a minimum retail price for dealers in China, the regulator has yet to specifically confirm such reports.

However, in around mid-August, the head of the Anti-Monopoly Bureau at the NDRC reportedly indicated on Chinese national television that the regulator could open investigations into the automobile as well as petroleum, banking and telecommunications industries.

In Part III – How to handle AML investigations

In the final part of this legal update, we provide some practical and high-level recommendations on how to deal with active enforcement of the AML by the various Anti-Monopoly Enforcement Authorities in China.

Visit us at

Mayer Brown is a global legal services organization comprising legal practices that are separate entities (the Mayer Brown Practices). The Mayer Brown Practices are: Mayer Brown LLP, a limited liability partnership established in the United States; Mayer Brown International LLP, a limited liability partnership incorporated in England and Wales; Mayer Brown JSM, a Hong Kong partnership, and its associated entities in Asia; and Tauil & Chequer Advogados, a Brazilian law partnership with which Mayer Brown is associated. "Mayer Brown" and the Mayer Brown logo are the trademarks of the Mayer Brown Practices in their respective jurisdictions.

© Copyright 2013. The Mayer Brown Practices. All rights reserved.

This article provides information and comments on legal issues and developments of interest. The foregoing is not a comprehensive treatment of the subject matter covered and is not intended to provide legal advice. Readers should seek specific legal advice before taking any action with respect to the matters discussed herein. Please also read the JSM legal publications Disclaimer.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Related Topics
Related Articles
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions